Flagship explainer
How Whitehawk Therapeutics, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $7.1M | 100% |
| |
| Cost of revenue | $760000 | 11% |
|
| $6.4M | 89% |
| |
| −$114M | −1601% |
| |
| Income before tax | −$20.6M | −288% |
|
| Income tax | $0 | 0% |
|
| −$20.6M | −288% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-104158